Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Aignostics, a Berlin-based AI company specializing in precision medicine, has secured $34 million (€31.4 million) in Series B funding. The company plans to use the funds to enhance its AI-driven precision medicine products, expand its presence in the US, and develop new models. Aignostics focuses on turning complex multi-modal pathology data into transformative insights. The funding round saw participation from investors including Team Athos and Mayo Clinic.
A huge congratulations to Zenity for raising $38M in Series B funding! ���� Read the full story here 👉 https://t.co/YeFhKu8Qeg
Congrats to @zenitysec on raising $38M in #SeriesB #funding! 🎉 Zenity will use the new funding to expand its agentless application security platform for its Fortune 500 customers as it increasingly leverages #lowcode and #AI applications. Learn more in @SiliconANGLE:…
Aignostics Raises $34 Million Series B to Accelerate Precision Medicine with AI Investors: @TeamATHOS @MayoClinic Follow AI Beat by #RiseAngle ; Leading Generative AI in Gaming https:// https://t.co/kL9tebvP69 #VC #AngelInvesting #ChatGPT https://t.co/5fXsEi1dRS